Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users

Gastroenterology

Volumn 144, Issue 3, 2013, Pages 528-535

  Chan, Francis K L ^a   Ching, Jessica Y L ^a   Suen, Bing Yee ^a   Tse, Yee Kit ^a   Wu, Justin C Y ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aspirin; H pylori; Low Dose Aspirin; Prediction; Stomach; Ulcer Bleeding

Indexed keywords

ACETYLSALICYLIC ACID; BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG USE; ENTERIC COATED TABLET; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SEPSIS; ULCER HEALING;

EID: 84874088293     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.12.038     Document Type: Article

References (25)

1. A.S. Taha, W.J. Angerson, R.P. Knill-Jones Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs-a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs Aliment Pharmacol Ther 22 2005 285 289
2. A.S. Taha, W.J. Angerson, R. Prasad Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin Aliment Pharmacol Ther 26 2007 1171 1178
3. J.J. Sung, J.Y. Lau, J.Y. Ching Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial Ann Intern Med 152 2010 1 9
4. P.M. Rothwell, F.G. Fowkes, J.F. Belch Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
5. G.V. Moukarbel, J.E. Signorovitch, M.A. Pfeffer Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial Eur Heart J 30 2009 2226 2232
6. F.K. Chan Anti-platelet therapy and managing ulcer risk J Gastroenterol Hepatol 27 2012 195 199
7. P. Serrano, A. Lanas, M.T. Arroyo Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Aliment Pharmacol Ther 16 2002 1945 1953
8. P. Malfertheiner, F. Megraud, C. O'Morain Management of Helicobacter pylori infection: the Maastricht IV/Florence Consensus Report Gut 61 2012 646 664
9. F.L. Lanza, F.K. Chan, E.M. Quigley Practice Parameters Committee of the American College of Gastroenterology Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 2009 728 738
10. D.L. Bhatt, J. Scheiman, N.S. Abraham ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 52 2008 1502 1517
11. F.K. Chan, S.C. Chung, B.Y. Suen Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 2001 967 973
12. K.C. Lai, S.K. Lam, K.M. Chu Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use N Engl J Med 346 2002 2033 2038
13. A. Pilotto, M. Franceschi, M.G. Longoa Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin Dig Liver Dis 36 2004 666 670
14. US Food and Drug Administration FDA reminder to avoid concomitant use of Plavix (clopidogrel) and omeprazole www.fda.gov/Drugs/DrugSafety/ucm231161.htm Accessed: April 5, 2012
15. The European Medicines Agency Public statement on possible interaction between clopidogrel and proton pump inhibitors http://www.emea.europa.eu/docs/ en-GB/document-library/Public-statement/2009/11/WC500014409.pdf Accessed: April 5, 2012
16. FDA Drug Safety Communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm213206.htm Accessed: April 18, 2012
17. L.C. Hung, J.Y. Ching, J.J. Sung Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study Gastroenterology 128 2005 1845 1850
18. G.L. Wong, V.W. Wong, Y. Chan High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers Gastroenterology 137 2009 525 531
19. J.S. Long, J. Freese Regression models for categorical dependent variables using Stata (revised edition) 2003 Stata Corporation College Station, TX
20. H.T. Sorensen, L. Mellemkjaer, W.J. Blot Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2000 2218 2224
21. D. Signorini Sample size for Poisson regression Biometrika 78 1991 446 450
22. J.P. Kelly, D.W. Kaufman, J.M. Jurgelon Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product Lancet 348 1996 1413 1416
23. A. Lanas, A. Ferrandez Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly Drugs Aging 24 2007 121 131
24. A.S. Taha, C. McCloskey, R. Prasad Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial Lancet 374 2009 119 125
25. J.W. Konturek, A. Dembinski, S.J. Konturek Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans Gastroenterology 114 1998 245 255